100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached 4.6 TrustPilot
logo-home
Exam (elaborations)

MSN571 Advanced Pharmacology - Final Exam Review(Qns & Ans)

Rating
-
Sold
1
Pages
33
Grade
A+
Uploaded on
27-06-2025
Written in
2024/2025

MSN571 Advanced Pharmacology - Final Exam Review(Qns & Ans) MSN571 Advanced Pharmacology - Final Exam Review(Qns & Ans)












Whoops! We can’t load your doc right now. Try again or contact support.

Document information

Uploaded on
June 27, 2025
Number of pages
33
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers

Subjects

Content preview

MSN571

Advanced Pharmacology

Final Exam Review

(Questions & Solutions)

2025




1

, Question 1
Case Scenario: A 7‑day‑old preterm neonate with suspected sepsis is
prescribed gentamicin. Given the neonate’s physiology, which
pharmacokinetic factor most increases the risk of toxicity in this age
group?
- A) Increased gastrointestinal motility
- B) Reduced glomerular filtration rate
- C) Enhanced protein binding
- D) Faster hepatic metabolism

Correct ANS: B
Rationale: Neonates have immature renal function, including a reduced
glomerular filtration rate, which decreases gentamicin clearance and
heightens the risk of toxicity.

---

Question 2
Case Scenario: A 4‑year‑old child is started on valproic acid for seizure
control. Compared with adults, pediatric patients often require dosing
adjustments.
Question: Which pharmacokinetic property in children generally
necessitates a higher mg/kg dosing of medications like valproic acid?
- A) Decreased metabolic clearance
- B) Lower distribution volume
- C) Increased hepatic enzyme activity relative to body weight
- D) Reduced renal excretion

Correct ANS: C
Rationale: Children often have a relatively higher metabolic rate and
increased hepatic enzyme activity per kilogram body weight, leading to
faster clearance of drugs and the need for proportionally higher dose-
per-weight regimens.
2

,---

Question 3
Case Scenario: A 30‑year‑old pregnant woman with epilepsy maintained
on lamotrigine experiences a breakthrough seizure during her second
trimester.
Question: Which pharmacokinetic change during pregnancy is most
likely responsible for the reduced plasma concentration of lamotrigine?
- A) Decreased renal clearance
- B) Increased plasma protein binding
- C) Upregulated hepatic metabolism (enzyme induction)
- D) Reduced gastrointestinal absorption

Correct ANS: C
Rationale: During pregnancy, estrogen‐mediated enzyme induction
upregulates hepatic metabolism, increasing lamotrigine clearance and
thereby lowering its plasma concentration, which may lead to
breakthrough seizures.

---

Question 4
Case Scenario: A 75‑year‑old female with insomnia is prescribed a
low‑dose, long‑acting benzodiazepine.
Question: Which age‑related physiological change most contributes to
prolonged drug half‑life in this patient?
- A) Reduced cardiac output
- B) Increased adipose tissue
- C) Increased plasma volume
- D) Enhanced first‑pass metabolism

Correct ANS: B
Rationale: With aging, an increased proportion of adipose tissue
provides a larger reservoir for lipophilic drugs (e.g., benzodiazepines),
3

, prolonging their half‑life and increasing the risk of accumulation and
adverse effects.

---

Question 5
Case Scenario: A 68‑year‑old man with chronic kidney disease is
prescribed a renally excreted antibiotic for pneumonia.
Question: Which principle should guide his medication management?
- A) Initiate drug therapy at standard doses regardless of renal function
- B) Adjust the dosage based on renal clearance measurements
- C) Use only parenteral routes to bypass hepatic metabolism
- D) Increase the dosing frequency to maintain therapeutic levels

Correct ANS: B
Rationale: In patients with reduced renal function, dose adjustments
based on measured renal clearance help avoid drug accumulation and
toxicity.

---

Question 6
Case Scenario: A 5‑year‑old child is being evaluated for an acute
infection. Compared to adults, pediatric patients demonstrate
differences in drug metabolism.
Question: Which statement best explains pediatric differences in drug
metabolism?
- A) Neonates and older children have uniformly reduced CYP enzyme
activity
- B) Infants generally have slower metabolism, but by age five,
increased liver size relative to body weight enhances drug clearance
- C) Pediatric patients eliminate drugs solely through renal pathways
- D) All drugs require the same dosing regimen across childhood and
adulthood


4

Get to know the seller

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
Bankart Chamberlain College of Nursing
View profile
Follow You need to be logged in order to follow users or courses
Sold
150
Member since
2 year
Number of followers
31
Documents
4512
Last sold
1 week ago

3.6

21 reviews

5
9
4
0
3
9
2
1
1
2

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Frequently asked questions